fish_oil_18
Findings on n-3 Fatty Acid Supplement Health Benefits
The results summarize each of the health outcomes for an experiment where 12,933 subjects received a 1g fish oil supplement daily and 12,938 received a placebo daily. The experiment's duration was 5-years.
Variables
- major_cardio_event - Major cardiovascular event. (Primary end point.)
- cardio_event_expanded - Cardiovascular event in expanded composite endpoint.
- myocardioal_infarction - Total myocardial infarction. (Heart attack.)
- stroke - Total stroke.
- cardio_death - Death from cardiovascular causes.
- PCI - Percutaneous coronary intervention.
- CABG - Coronary artery bypass graft.
- total_coronary_heart_disease - Total coronary heart disease.
- ischemic_stroke - Ischemic stroke.
- hemorrhagic_stroke - Hemorrhagic stroke.
- chd_death - Death from coronary heart disease.
- myocardial_infarction_death - Death from myocardial infraction.
- stroke_death - Death from stroke.
- invasive_cancer - Invasive cancer of any type. (Primary end point.)
- breast_cancer - Breast cancer.
- prostate_cancer - Prostate cancer.
- colorectal_cancer - Colorectal cancer.
- cancer_death - Death from cancer.
- death - Death from any cause.
- major_cardio_event_after_2y - Major cardiovascular event, excluding the first 2 years of follow-up.
- myocardial_infarction_after_2y - Total myocardial infarction, excluding the first 2 years of follow-up.
- invasive_cancer_after_2y - Invasive cancer of any type, excluding the first 2 years of follow-up.
- cancer_death_after_2y - Death from cancer, excluding the first 2 years of follow-up.
- death_after_2y - Death from any cause, excluding the first 2 years of follow-up.
Source
Manson JE, et al. 2018. Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer. NEJMoa1811403. https://www.nejm.org/doi/full/10.1056/NEJMoa1811403